PEMAZYRE
PEMAZYRE
Approved
DIN Number
02519933
Drug Class
Human
Market Date
Jan 6, 2022
Company
HC
因塞特
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02519933
AIG Number0163133001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L01EN02 PEMIGATINIB
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
PEMIGATINIBActive
Strength: 4.5 MG
Monograph: PEMIGATINIB